Immix Biopharma, Inc. - Common Stock (IMMX)

CUSIP: 45258H106

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock
Shares outstanding
52,769,253
Total 13F shares
2,870,949
Share change
-1,241,218
Total reported value
$6,315,600
Put/Call ratio
7.8%
Price per share
$2.20
Number of holders
22
Value change
-$1,857,745
Number of buys
6
Number of sells
13

Security key

45258H106

Report period

Q4 2024

Institutions

22

Top holders

10

Top shareholders of IMMX - Immix Biopharma, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
AIGH Capital Management LLC
13F
Company
2.1%
1,123,663
$1,674,258 30 Sep 2024
13F
Bleichroeder LP
13F
Company
1.6%
850,000
$1,266,500 30 Sep 2024
13F
Cable Car Capital, LP
13F
Company
1.5%
796,100
$1,186,189 30 Sep 2024
13F
VANGUARD GROUP INC
13F
Company
1.3%
698,537
$1,040,820 30 Sep 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.28%
150,082
$223,651 30 Sep 2024
13F
MORGAN STANLEY
13F
Company
0.16%
84,313
$125,626 30 Sep 2024
13F
ROYAL BANK OF CANADA
13F
Company
0.16%
84,000
$125,000 30 Sep 2024
13F
TOCQUEVILLE ASSET MANAGEMENT L.P.
13F
Company
0.08%
43,300
$64,517 30 Sep 2024
13F
STATE STREET CORP
13F
Company
0.08%
42,960
$64,010 30 Sep 2024
13F
NORTHERN TRUST CORP
13F
Company
0.07%
38,914
$57,982 30 Sep 2024
13F
Private Advisor Group, LLC
13F
Company
0.07%
34,325
$51,145 30 Sep 2024
13F
Invst, LLC
13F
Company
0.05%
27,000
$40,230 30 Sep 2024
13F
COMMONWEALTH EQUITY SERVICES, LLC
13F
Company
0.05%
26,080
$39,000 30 Sep 2024
13F
TRITONPOINT WEALTH, LLC
13F
Company
0.05%
24,526
$38,261 30 Sep 2024
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.04%
21,521
$32,066 30 Sep 2024
13F
BlackRock, Inc.
13F
Company
0.03%
14,003
$20,864 30 Sep 2024
13F
Focus Partners Wealth
13F
Company
0.02%
11,900
$17,731 30 Sep 2024
13F
OLD NATIONAL BANCORP /IN/
13F
Company
0.02%
10,000
$14,900 30 Sep 2024
13F
UBS Group AG
13F
Company
0.01%
6,146
$9,158 30 Sep 2024
13F
Tower Research Capital LLC (TRC)
13F
Company
0.01%
3,110
$4,634 30 Sep 2024
13F
Steward Partners Investment Advisory, LLC
13F
Company
0%
1,492
$2,223 30 Sep 2024
13F
Tortoise Investment Management, LLC
13F
Company
0%
1,300
$1,937 30 Sep 2024
13F
OSAIC HOLDINGS, INC.
13F
Company
0%
950
$1,416 30 Sep 2024
13F
WELLS FARGO & COMPANY/MN
13F
Company
0%
330
$492 30 Sep 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
115
$171 30 Sep 2024
13F
Sean Senn
3/4/5
Under 10% owner
class O/S missing
899,800
$4,205,665 14 Jul 2022
Vladimir P. Torchilin
3/4/5
Scientific Co-Founder
class O/S missing
905,200
$4,230,905 20 Dec 2021

Institutional Holders of Immix Biopharma, Inc. - Common Stock (IMMX) as of Q4 2024

As of 31 Dec 2024, Immix Biopharma, Inc. - Common Stock (IMMX) was held by 22 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,870,949 shares. The largest 10 holders included Bleichroeder LP, Cable Car Capital, LP, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, STATE STREET CORP, NORTHERN TRUST CORP, TOCQUEVILLE ASSET MANAGEMENT L.P., Private Advisor Group, LLC, and FNY Investment Advisers, LLC. This page lists 22 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders
25
Q4 2024 holders
22
Holder diff
-3
Investor Q3 2024 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2024 Value $ Q4 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .